Vardzel Gerald J Jr 4
4 · Precision Therapeutics Inc. · Filed Apr 8, 2019
Insider Transaction Report
Form 4
Vardzel Gerald J Jr
Director
Transactions
- Award
Common Stock, $.01 par value
2019-04-04+718,205→ 718,205 total - Award
Stock Options (right to buy)
2019-04-04+151,260→ 151,260 totalExercise: $0.75Exp: 2029-04-04→ Common Stock (151,260 underlying) - Other
Common Stock, $.01 par value
2019-04-04+197,506→ 197,506 total
Footnotes (3)
- [F1]The reporting person acquired 718,205 shares of issuer common stock in exchange for an 18% interest in Helomics Holding Corporation ("Helomics") pursuant to Helomics merger into the issuer. The shares are valued at $0.7480 per share, the closing price on the date of the closing, 4/4/2019. Of the 718,205 shares issued to the reporting person in the merger, 175,411 are currently being held in escrow and are subject to forfeiture during the escrow period (until 9/30/2020), to satisfy any claims arising as a result of any breach by Helomics of any of its representations and warranties or covenants in the merger agreement.
- [F2]Shares released from escrow.
- [F3]37,815 shares vest immediately and 37,815 vest on 10/4/2019; the remainder vests quarterly for 18 months.